Prostatis Group’s State Street SPDR NYSE Technology ETF XNTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.56M Buy
37,438
+4,285
+13% +$1.17M 2.45% 7
2025
Q4
$9.21M Sell
33,153
-4,326
-12% -$1.21M 2.2% 9
2025
Q3
$10.2M Buy
+37,479
New +$9.23M 2.56% 5

Other funds holding XNTK

Prostatis Group's XNTK Position: Q1 2026 in Review

Prostatis Group increased its State Street SPDR NYSE Technology ETF (XNTK) stake by 13% in Q1 2026, buying an estimated $1.17M and bringing the position to 37,438 shares worth $9.56M. The position accounts for 2.45% of the portfolio, ranked #7.

Prostatis Group first reported a position in XNTK in Q3 2025 and has held it in 3 quarters since. The position peaked at $10.2M in Q3 2025. 198 funds tracked by Wall St. Rank hold XNTK as of Q1 2026.

  • Prostatis Group held 37,438 shares of State Street SPDR NYSE Technology ETF worth $9.56M as of Q1 2026.
  • Prostatis Group bought 4,285 State Street SPDR NYSE Technology ETF shares in Q1 2026, an estimated $1.17M.
  • State Street SPDR NYSE Technology ETF made up 2.45% of Prostatis Group's portfolio in Q1 2026, its #7 holding.
  • Prostatis Group first reported a position in State Street SPDR NYSE Technology ETF in Q3 2025 and has held it in 3 quarters since.
  • Prostatis Group's State Street SPDR NYSE Technology ETF position peaked at $10.2M in Q3 2025.
  • 198 funds tracked by Wall St. Rank held State Street SPDR NYSE Technology ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.